PRION DISEASE INFECTIVITY CAUSES HEART DAMAGE IN MOUSE STUDY

[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]

 



U.S. Department of Health and Human Services 
NATIONAL INSTITUTES OF HEALTH 
NIH News 
National Institute of Allergy and Infectious Diseases (NIAID) 
http://www3.niaid.nih.gov/ 

EMBARGOED FOR RELEASE: Thursday, July 6, 2006, 2:00 p.m. ET

CONTACT: Ken Pekoc, 406-375-9690, kpekoc@xxxxxxxxxxxxx

PRION DISEASE INFECTIVITY CAUSES HEART DAMAGE IN MOUSE STUDY

Laboratory mice infected with the agent of scrapie -- a brain-wasting
disease of sheep -- show high levels of the scrapie agent in their heart
several hundred days after being infected in the brain, indicating that
heart infection might be a new aspect of this disease, according to a
research paper released online today by the journal "Science."

Collaborators in the work include scientists at the Rocky Mountain
Laboratories (RML), part of the National Institute of Allergy and
Infectious Diseases (NIAID) of the National Institutes of Health.

"Undoubtedly, this work will enable scientists to pursue new theories
about the effects of these deadly brain wasting diseases," says NIH
Director Elias A. Zerhouni, M.D. "The implications of this research
could be vital to our efforts to slow or stop these diseases."

"Although much work remains to be done, the diseased hearts seen in this
mouse study have similarities to human amyloid heart disease, which is
potentially significant," says NIAID Director Anthony S. Fauci, M.D.

Scrapie belongs to a group of diseases called prion diseases, also known
as transmissible spongiform encephalopathies or TSEs because of the
sponge-like holes created in the brain. In addition to scrapie in sheep,
prion diseases include Creutzfeldt-Jacob disease in humans, mad cow
disease in cattle and chronic wasting disease in deer and elk. The cause
of prion diseases, still under debate, may be abnormal aggregated forms
of prion protein.

The new research has provided cardiologists an animal model in which to
study heart amyloidosis, a family of heart diseases that affect humans,
says Bruce Chesebro, M.D., an RML virologist and a senior author of the
new paper. Amyloidoses involve waxy protein deposits that stiffen the
heart, limit its pumping ability and typically lead to fatal heart
stoppage.

"Although several types of protein are known to form heart amyloid, this
is the first time prion protein amyloid has been found in heart muscle
and also found to cause heart malfunction," says Dr. Chesebro. "That's
exciting for cardiologists, because this study connects the two fields
of research."

Last year, Dr. Chesebro's research group from Hamilton, MT, collaborated
with Michael Oldstone, M.D., and other researchers at The Scripps
Research Institute in La Jolla, CA, and learned that scrapie-infected
mice engineered without an "anchor" between the membrane of cells and
the prion protein regularly lived for more than 600 days, ultimately
dying of old age, according to Dr. Chesebro. Wild mice infected with
scrapie typically die after about 150 days.

In this earlier research, signs of prion protein amyloid were most
prominent near blood vessels in the mouse brain. In the newly reported
study, researchers at Scripps found similar amyloid in heart muscle.
They then secured the help of Kirk Knowlton, M.D., chief of the division
of cardiology at the University of California, San Diego, who
investigated the effect of prion protein amyloid on mouse heart
function, discovering that it decreased the heart's ability to pump
blood.

Unusually high levels of scrapie infectivity were also found in the
blood of the same mice used in the heart study. In the future, this
finding could help scientists develop a blood-based diagnostic test to
identify brain-wasting diseases and possibly lead to a way to filter or
chemically treat blood to remove any infectious prion disease agents,
says Dr. Chesebro.

News releases, fact sheets and other NIAID-related materials are
available on the NIAID Web site at http://www.niaid.nih.gov.

NIAID is a component of the National Institutes of Health. NIAID
supports basic and applied research to prevent, diagnose and treat
infectious diseases such as HIV/AIDS and other sexually transmitted
infections, influenza, tuberculosis, malaria and illness from potential
agents of bioterrorism. NIAID also supports research on basic
immunology, transplantation and immune-related disorders, including
autoimmune diseases, asthma and allergies.

The National Institutes of Health (NIH) -- "The Nation's Medical
Research Agency" -- includes 27 Institutes and Centers and is a
component of the U.S. Department of Health and Human Services. It is the
primary federal agency for conducting and supporting basic, clinical and
translational medical research, and it investigates the causes,
treatments, and cures for both common and rare diseases. For more
information about NIH and its programs, visit www.nih.gov.

---------------------------------------------
References: MJ Trifilo "et al." Prion-induced amyloid heart disease with
high blood infectivity in transgenic mice. "Science" 313:94-97 (2006).
DOI: 10.1126/science.1128635. 

B Chesebro "et al." Anchorless prion protein results in infectious
amyloid disease without clinical scrapie. "Science" 308 (5727):1435-39
(2005). DOI: 10.1126/science.1110837.
---------------------------------------------  
##
 
This NIH News Release is available online at:
http://www.nih.gov/news/pr/jul2006/niaid-06.htm.

To subscribe (or unsubscribe) from this list, go to
http://list.nih.gov/cgi-bin/wa?SUBED1=nihpress&A=1.

[Index of Archives]     [CDC News]     [FDA News]     [USDA News]     [Yosemite News]     [Steve's Art]     [PhotoForum]     [SB Lupus]     [STB]

  Powered by Linux